Clinical Trials Directory

Trials / Unknown

UnknownNCT04946617

Chlorhexidine and Essential Oil Mouthwashes on Human Beta-Defensin 2 (hbD2) and Kathelicidin (LL-37) Saliva Levels

The Effect of Chlorhexidine and Essential Oil Mouthwashes on Human Beta-Defensin 2 (hbD2) and Kathelicidin (LL-37) Saliva Levels

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Istanbul Medeniyet University · Academic / Other
Sex
All
Age
25 Years – 40 Years
Healthy volunteers

Summary

Recent studies have shown that while mouthwashes exhibit antimicrobial properties against bacteria and their products, at the same time showing the cytotoxic effect on living cells in the mouth.29 To the best of our knowledge, there is no information about the toxicity effect of these two mouthwashes, which are highly preferred, on antimicrobial peptides secreted from the oral epithelium. Therefore, our aim in this study is to evaluate the effect of chlorhexidine and essential oil mouthwash on hBD2 and LL-37 in saliva.

Detailed description

Periodontal health continues with a balanced interaction of the oral microflora with the host defense line.

Conditions

Interventions

TypeNameDescription
DRUGundefinedRinsing with mouthwashes

Timeline

Start date
2021-07-20
Primary completion
2021-12-20
Completion
2021-12-20
First posted
2021-07-01
Last updated
2021-07-01

Source: ClinicalTrials.gov record NCT04946617. Inclusion in this directory is not an endorsement.